Patrocinado

Bharat Bio successfully completes Phase III trials of new oral cholera vaccine Hillchol

Bharat Biotech's oral cholera vaccine, Hillchol, has demonstrated successful Phase III clinical trial results, proving effective against both Ogawa and Inaba serotypes. The vaccine exhibited a significant rise in vibriocidal antibodies and maintained a strong safety profile across all age groups. With production capacity of 200 million doses, Hillchol can address the global cholera crisis and vaccine shortages.
Pesquisar
Categorias
Leia Mais
One killed, another injured in lightning strike in Taplejung
TAPLEJUNG: A man has died and another has been injured after being struck by lightning in...
Por HamroGlobal 0 8
Neena Gupta opens up about her FIRST husband
Neena Gupta reminisced about her early romances. Her first love was an IIT student, whom she...
Por BharatUpdates 0 11
RCB stampede chargesheet only after HC nod
Por BharatUpdates 0 18
Leaked audio implicates former Bangladeshi leader Hasina in deadly protest crackdown
DHAKA: Former Bangladeshi Prime Minister Sheikh Hasina directly ordered security forces to use...
Por HamroGlobal 0 20
Is Payal and Sangram headed for a divorce
Rumors of separation surround Payal Rohatgi and Sangram Singh after Payal resigned from Sangram's...
Por BharatUpdates 0 24